Page last updated: 2024-10-25

ciclopirox and Innate Inflammatory Response

ciclopirox has been researched along with Innate Inflammatory Response in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Ciclopirox (CPX) is a broad-spectrum antimycotic agent which also exerts anti-inflammatory effects in human diseases."1.91Ciclopirox mitigates inflammatory response in LPS-induced septic shock via inactivation of SORT1-mediated wnt/β-Catenin signaling pathway. ( Chen, J; Deng, Y; He, Y; Li, X; Wang, W; Zhou, L, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Liang, S1
Yang, Z1
Hua, L1
Chen, Y1
Zhou, Y1
Ou, Y1
Chen, X1
Yue, H1
Yang, X1
Wu, X1
Hu, W1
Sun, P1
Zhou, L1
He, Y1
Deng, Y1
Li, X1
Wang, W1
Chen, J1

Other Studies

2 other studies available for ciclopirox and Innate Inflammatory Response

ArticleYear
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice.
    European journal of pharmacology, 2022, Sep-05, Volume: 930

    Topics: Animals; Ciclopirox; Imiquimod; Inflammasomes; Inflammation; Interleukin-1beta; Lipopolysaccharides;

2022
Ciclopirox mitigates inflammatory response in LPS-induced septic shock via inactivation of SORT1-mediated wnt/β-Catenin signaling pathway.
    Immunopharmacology and immunotoxicology, 2023, Volume: 45, Issue:6

    Topics: Animals; beta Catenin; Ciclopirox; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbr

2023